Sökresultat - R. Katherine Alpaugh

Förfina resultatet
  1. 1
    Circulating tumor cells: silent predictors of metastasis

    Circulating tumor cells: silent predictors of metastasis av Lanlan Zhou, David T. Dicker, Elizabeth Matthew, Wafik S. El‐Deiry, R. Katherine Alpaugh

    Publicerad 2017
    Hämta fulltext Hämta fulltext
    Pré-impressão
    Lägg till i favoriter
    Sparad:
  2. 2
    Multi-Phenotypic subtyping of circulating tumor cells using sequential fluorescent quenching and restaining

    Multi-Phenotypic subtyping of circulating tumor cells using sequential fluorescent quenching and restaining av Daniel L. Adams, R. Katherine Alpaugh, Susan Tsai, Cha-Mei Tang, Steingrimur Stefansson

    Publicerad 2016
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  3. 3
    Bispecific Minibodies Targeting HER2/neu and CD16 Exhibit Improved Tumor Lysis When Placed in a Divalent Tumor Antigen Binding Format

    Bispecific Minibodies Targeting HER2/neu and CD16 Exhibit Improved Tumor Lysis When Placed in a Divalent Tumor Antigen Binding Format av Lillian Shahied, Yong Tang, R. Katherine Alpaugh, Robert A. Somer, Dana Greenspon, Louis M. Weiner

    Publicerad 2004
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  4. 4
    Blocking NK Cell Inhibitory Self-Recognition Promotes Antibody-Dependent Cellular Cytotoxicity in a Model of Anti-Lymphoma Therapy

    Blocking NK Cell Inhibitory Self-Recognition Promotes Antibody-Dependent Cellular Cytotoxicity in a Model of Anti-Lymphoma Therapy av Liat Binyamin, R. Katherine Alpaugh, Tracey L. Hughes, Charles T. Lutz, Kerry S. Campbell, Louis M. Weiner

    Publicerad 2008
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  5. 5
    Regulation of Antibody-Dependent Cellular Cytotoxicity by IgG Intrinsic and Apparent Affinity for Target Antigen

    Regulation of Antibody-Dependent Cellular Cytotoxicity by IgG Intrinsic and Apparent Affinity for Target Antigen av Yong Tang, Jianlong Lou, R. Katherine Alpaugh, Matthew K. Robinson, James D. Marks, Louis M. Weiner

    Publicerad 2007
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  6. 6
    Mutational studies on single circulating tumor cells isolated from the blood of inflammatory breast cancer patients

    Mutational studies on single circulating tumor cells isolated from the blood of inflammatory breast cancer patients av Catherine April Bingham, Sandra V. Fernandez, Patricia Fittipaldi, Paul W. Dempsey, Karen Ruth, Massimo Cristofanilli, R. Katherine Alpaugh

    Publicerad 2017
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  7. 7
    Cytometric characterization of Circulating Tumor Cells Captured by microfiltration and their correlation to the cellsearch<sup>®</sup> CTC test

    Cytometric characterization of Circulating Tumor Cells Captured by microfiltration and their correlation to the cellsearch<sup>®</sup> CTC test av Daniel L. Adams, Steingrimur Stefansson, Christian Haudenschild, Stuart S. Martin, Monica S. Charpentier, Saranya Chumsri, Massimo Cristofanilli, Cha‐Mei Tang, R. Katherine Alpaugh

    Publicerad 2014
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  8. 8
    Circulating Cancer-Associated Macrophage-Like Cells Differentiate Malignant Breast Cancer and Benign Breast Conditions

    Circulating Cancer-Associated Macrophage-Like Cells Differentiate Malignant Breast Cancer and Benign Breast Conditions av Daniel L. Adams, Diane K. Adams, R. Katherine Alpaugh, Massimo Cristofanilli, Stuart S. Martin, Saranya Chumsri, Cha-Mei Tang, Jeffrey R. Marks

    Publicerad 2016
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  9. 9
    Mitosis in circulating tumor cells stratifies highly aggressive breast carcinomas

    Mitosis in circulating tumor cells stratifies highly aggressive breast carcinomas av Daniel L. Adams, Diane K. Adams, Steingrimur Stefansson, Christian Haudenschild, Stuart S. Martin, Monica S. Charpentier, Saranya Chumsri, Massimo Cristofanilli, Cha-Mei Tang, R. Katherine Alpaugh

    Publicerad 2016
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  10. 10
    NK cell dysfunction in chronic lymphocytic leukemia is associated with loss of the mature cells expressing inhibitory killer cell Ig-like receptors

    NK cell dysfunction in chronic lymphocytic leukemia is associated with loss of the mature cells expressing inhibitory killer cell Ig-like receptors av Alexander W. MacFarlane, Mowafaq Jillab, Mitchell R. Smith, R. Katherine Alpaugh, Marion Cole, Samuel Litwin, Michael Millenson, Tahseen Al‐Saleem, Adam D. Cohen, Kerry S. Campbell

    Publicerad 2017
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  11. 11
    CD16+ monocytes in patients with cancer: spontaneous elevation and pharmacologic induction by recombinant human macrophage colony- stimulating factor

    CD16+ monocytes in patients with cancer: spontaneous elevation and pharmacologic induction by recombinant human macrophage colony- stimulating factor av MN Saleh, SJ Goldman, AF LoBuglio, Beall Ac, Hernan Sabio, MC McCord, Lori M. Minasian, R. Katherine Alpaugh, L M Weiner, David H. Munn

    Publicerad 1995
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  12. 12
    Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: A Gynecologic Oncology Group study

    Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary periton... av Kian Behbakht, Michael W. Sill, Kathleen M. Darcy, Stephen C. Rubin, Robert S. Mannel, Steven Waggoner, Russell J. Schilder, Kathy Q. Cai, Andrew K. Godwin, R. Katherine Alpaugh

    Publicerad 2011
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  13. 13
    Circulating giant macrophages as a potential biomarker of solid tumors

    Circulating giant macrophages as a potential biomarker of solid tumors av Daniel L. Adams, Stuart S. Martin, R. Katherine Alpaugh, Monica S. Charpentier, Susan Tsai, Raymond C. Bergan, Irene Ogden, William J. Catàlona, Saranya Chumsri, Cha-Mei Tang, Massimo Cristofanilli

    Publicerad 2014
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  14. 14
    Individualized Patient Dosing in Phase I Clinical Trials: The Role of Escalation With Overdose Control in PNU-214936

    Individualized Patient Dosing in Phase I Clinical Trials: The Role of Escalation With Overdose Control in PNU-214936 av Jonathan D. Cheng, James S. Babb, Corey J. Langer, Steinar Aamdal, Francisco Robert, Lars Engelhardt, Olov Fernberg, Joan H. Schiller, G. Forsberg, R. Katherine Alpaugh, Louis M. Weiner, André Rogatko

    Publicerad 2004
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  15. 15
    Response of an <i>ERBB2</i>-Mutated Inflammatory Breast Carcinoma to Human Epidermal Growth Factor Receptor 2–Targeted Therapy

    Response of an <i>ERBB2</i>-Mutated Inflammatory Breast Carcinoma to Human Epidermal Growth Factor Receptor 2–Targeted Therapy av Siraj M. Ali, R. Katherine Alpaugh, Sean R. Downing, Philip J. Stephens, Jian Yu, Hong Wu, Jamie Buell, Vincent A. Miller, Doron Lipson, Gary A. Palmer, Jeffrey S. Ross, Massimo Cristofanilli

    Publicerad 2014
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  16. 16
    Prognostic Significance of MUC-1 in Circulating Tumor Cells in Patients With Metastatic Pancreatic Adenocarcinoma

    Prognostic Significance of MUC-1 in Circulating Tumor Cells in Patients With Metastatic Pancreatic Adenocarcinoma av Efrat Dotan, R. Katherine Alpaugh, Karen Ruth, Benjamin P. Negin, Crystal S. Denlinger, Michael J. Hall, Igor Astsaturov, C McAleer, Patricia Fittipaldi, Catherine Thrash-Bingham, Neal J. Meropol, Steven J. Cohen

    Publicerad 2016
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  17. 17
    Phase II trial of chemotherapy, cetuximab and erlotinib in patients with metastatic or recurrent squamous cell carcinoma of the head and neck.

    Phase II trial of chemotherapy, cetuximab and erlotinib in patients with metastatic or recurrent squamous cell carcinoma of the head and neck. av Aarti Bhatia, Ranee Mehra, Jessica R. Bauman, Saad A. Khan, Wei Wei, Veronique Neumeister, Teresa Sandoval-Schaefer, R. Katherine Alpaugh, Miriam N. Lango, David L. Rimm, John A. Ridge, Barbara Burtness

    Publicerad 2025
    Hämta fulltext
    Pré-impressão
    Lägg till i favoriter
    Sparad:
  18. 18
    Phase II evaluation of dasatinib in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: A Gynecologic Oncology Group study

    Phase II evaluation of dasatinib in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: A Gynecologic Oncology Group study av Russell J. Schilder, William E. Brady, Heather A. Lankes, James V. Fiorica, Mark S. Shahin, Xun Zhou, Robert S. Mannel, Harsh B. Pathak, Wei Hu, R. Katherine Alpaugh, Anil K. Sood, Andrew K. Godwin

    Publicerad 2012
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  19. 19
    Biodistribution and Radiation Dosimetry of the Integrin Marker <sup>18</sup>F-RGD-K5 Determined from Whole-Body PET/CT in Monkeys and Humans

    Biodistribution and Radiation Dosimetry of the Integrin Marker <sup>18</sup>F-RGD-K5 Determined from Whole-Body PET/CT in Monkeys and Humans av Mohan Doss, Hartmuth C. Kolb, Jinjun Zhang, Marie-José Bélanger, James B. Stubbs, Michael G. Stabin, Eric D. Hostetler, R. Katherine Alpaugh, Margaret von Mehren, Joseph C. Walsh, Michael Haka, Vani P. Mocharla, Jian Q. Yu

    Publicerad 2012
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  20. 20
    Pembrolizumab monotherapy in patients with previously treated metastatic high-grade neuroendocrine neoplasms: joint analysis of two prospective, non-randomised trials

    Pembrolizumab monotherapy in patients with previously treated metastatic high-grade neuroendocrine neoplasms: joint analysis of two prospective, non-randomised trials av Namrata Vijayvergia, Arvind Dasari, Mengying Deng, Samuel Litwin, Taymeyah Al‐Toubah, R. Katherine Alpaugh, Efrat Dotan, Michael J. Hall, Nicole Ross, Melissa M. Runyen, Crystal S. Denlinger, Daniel M. Halperin, Steven J. Cohen, Paul F. Engstrom, Jonathan Strosberg

    Publicerad 2020
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:

Sökverktyg: